EMA Committee’s Negative Opinion for Eisai Alzheimer’s Drug Focuses on Safety Risks
Eisai’s efforts to bring its FDA-approved Alzheimer’s disease drug to patients in Europe have hit a setback. A European Medicines ...
Tag: drug
European regulators say Alzheimer’s drug should be rejected
LONDON — European regulators on Friday said that an Alzheimer’s therapy from Eisai and Biogen should be rejected, again diverging ...
Sage suffers pipeline setback with failure of drug to treat essential tremor
Sage Therapeutics said Wednesday that an experimental pill failed to quell involuntary muscle shaking in patients with a neurological condition ...
Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test
An Ionis Pharmaceuticals drug in development for Angelman syndrome has mid-stage clinical trial results showing improvement across a range of ...
Heartburn Drug from Phathom Pharma Expands Its Approval to Cover More GERD Patients
The millions of people who regularly suffer from heartburn now have a new FDA-approved treatment option, a Phathom Pharmaceuticals drug ...
Roche Weighs In With Encouraging Early Clinical Data for Oral GLP-1 Drug
Roche is a relative latecomer to GLP-1 metabolic dysfunction medication, however an oral drug candidate that got here as a ...
Roche’s oral obesity drug leads to weight loss in early study
LONDON — Roche on Wednesday reported optimistic early information from one other of the weight problems drug candidates that it ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!